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Abstract
Background: Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica
subspecies enterica serotype typhi, which is acquired by ingestion of contaminated food and water.
Each year the disease affects at least 16 million persons world-wide, most of whom reside in the
developing countries of Southeast Asia and Africa. In Italy the disease is uncommon with a greater
number of cases in Southern regions than in Northern ones.
Case presentation: We report on a 57-year-old Sri-Lankan male affected by typhoid fever, the
onset of which was accompanied by oropharyngeal candidiasis. This clinical sign was due to a
transient cell-mediated immunity depression (CD4+ cell count was 130 cells/mm3) probably caused
by Salmonella typhi infection. Human immunodeficiency virus infection was ruled out. Diagnosis of
typhoid fever was made by the isolation of Salmonella typhi from two consecutive blood cultures.
The patient recovered after a ten days therapy with ciprofloxacin and his CD4+ cell count
improved gradually until normalization within 3 weeks.
Conclusion: Our patient is the first reported case of typhoid fever associated with oropharyngeal
candidiasis. This finding suggests a close correlation between Salmonella typhi infection and
transitory immunodepression.
Background
Typhoid fever is a systemic infection caused by the bacte-
rium Salmonella enterica subspecies enterica serotype Typhi,
which is acquired by ingestion of contaminated food and
water. Each year the disease affects at least 16 million per-
sons world-wide, most of whom reside in the developing
countries of Southeast Asia and Africa [1]. Typhoid fever
is uncommon in industrialised regions such as the USA,
Canada, Europe, Australia and Japan and new cases of the
disease in these countries are related to travel to develop-
ing countries [2,3]. Based on such data, the public health
authorities in most industrialised countries recommend
vaccination against typhoid fever for travellers to the
developing world, where sanitary conditions are poor [4].
Italy is a low endemicity country for typhoid fever and a
greater number of cases occur in Southern regions than in
Northern ones. Sicily is the second region of our country
for incidence, with a mean of 100 annual cases in the last
five years.
Although typhoid fever is classically described as an acute
illness with fever and abdominal tenderness, the symp-
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toms are non specific and may be insidious in onset [5].
The diagnosis of enteric fever should be seriously consid-
ered in the evaluation of travellers who return from tropi-
cal and subtropical areas with fever. Mortality rates
associated with typhoid fever vary from region to region,
with the highest reported from Indonesia, Nigeria, and
India [6].
We report on an imported case of typhoid fever, the onset
of which was accompanied by oropharyngeal candidiasis.
Case presentation
In November 2004, a 57-year-old Sri-Lankan male turned
up at the emergency department of our hospital. The
patient had been living in Italy for 14 years, when he went
back home to Sri-Lanka. He was there for 2 months,
before returning to Italy where, few days later, he began
suffering from fever, malaise, headache and non produc-
tive cough. He turned up at the emergency department of
our hospital after 10 days from the beginning of symp-
toms.
On the basis of anamnestic data no history of drinking,
smoking and illicit drug abuse was reported. Moreover, in
his medical history there was no evidence of serious ill-
ness, such as diabetes mellitus or human immunodefi-
ciency virus (HIV) infection. The patient had not been
using proton pump inhibitors of stomach acid tablets,
neither oral glycocorticosteroids or inhalation corticoster-
oids. Moreover, he did not need to take any antibiotics
during his stay in Sri-Lanka.
The patient had a blood pressure of 180/100 mm Hg, a
heart rate of 120 beats/min, a respiratory rate of 16
breaths/min, and a temperature of 38.9°C. On chest
examination bilateral scattered rhonchi and mild rales
were audible at the base of both the man's lungs. A chest
radiograph revealed accentuation of the pulmonary retic-
ulum, more marked on the right, but no clear signs of con-
solidation. The rest of the examination was notable for a
minimally distended abdomen which was diffusely ten-
der. Laboratory examination revealed a white blood cells
(WBC) count of 6,400 cells/mm3 (normal range 4,000–
10,000 cells/ mm3), a haemoglobin level of 15 g/dl (12–
17 g/dl), a platelet count of 189,000 cells/mm3 (150,000
– 450,000 cells/mm3), an aspartate amino-transferase
level of 71 U/L, an alanine aminotransferase level of 98 U/
L; blood glucose level, serum electrolyte concentrations
and renal function tests were within normal limits. A pre-
sumptive diagnosis of bronchitis was made, and the
patient was transferred to our infectious disease depart-
ment.
At the time of admission, the patient was persistently
febrile (39°C). On physical examination we noted dry
skin and oral candidiasis characterized by creamy white,
curdlike patches on the tongue; this clinical picture was so
typical that it did not need a culture to confirm the diag-
nosis of oral candidiasis. His abdomen was diffusely ten-
der to palpation and without recognizable
hepatosplenomegaly. Cultures of blood and respiratory
specimens were performed. Thick and thin blood smears
for malaria were obtained.
Treatment with topical nystatin and empirical therapy
with ciprofloxacin (500 mg iv every 12 hours) were
started. Because of the oro pharyngeal candidiasis, lym-
phocyte count was taken, the absolute number of lym-
phocytes was 562 cells/ mm3. The CD4+ cell count was
130 cells/mm3while the CD8+ was 240; as a second step
an HIV test (ELISA) was performed and was negative. To
rule out a very recent infection a qualitative HIV PCR was
performed and HIV RNA was undetectable. On the 3rd
day of hospitalisation, a Salmonella species identified as S.
typhi was isolated from the two consecutive blood cultures
obtained on the day of admission. Isolates were suscepti-
ble to ampicillin, cotrimoxazole, chloramphenicol, cefo-
taxime, ceftriaxone, and ciprofloxacin with the standard
disk diffusion susceptibility testing method. The patient
continued ciprofloxacin for a total of 10 days; he became
afebrile after 3 days of therapy and his oral candidiasis
improved slowly with nistatin. The patient recovered and
was discharged from the hospital on the 10th day. At that
time, his CD4+ cell count was 622 cells/mm3.
On the 20th day after discharge and in the 3rd month of
follow-up, the patient was symptom free and his CD4+
cell count was raised to 1,080 and 1,200 cells/mm3 respec-
tively.
Conclusion
In Italy, typhoid fever has become an uncommon disease
occurring mainly as a sporadic disease in patients of any
age and gender, and at any time of the year. The preva-
lence rate of typhoid fever has markedly decreased, from
nearly 10,000 documented cases annually in the 1970s to
a few hundred cases annually in the 2000s [7,8]. This data
suggest that Italy is still a low endemicity country for
typhoid fever, because of the presence of a moderate
number of autochthonous cases mainly reported in the
Southern regions of our country [9]. Nevertheless, S. typhi
infection is one of the major causes of fever in patients
admitted in hospital after returning from the tropics.
Together with hepatitis A it represents the cause of a sig-
nificant number of hospitalizations that pretravel vaccina-
tion strategies could have prevented [10].
Recently many strains of multidrug resistant (MDR) S.
typhi have been identified worldwide [11-14]; in Italy an
epidemiologic study conducted between 1980 and 1996BMC Infectious Diseases 2006, 6:38 http://www.biomedcentral.com/1471-2334/6/38
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showed that their spread was until now quite low [15].
However an accurate and continuous surveillance is nec-
essary in order to quickly identify MDR S. typhi strains and
prevent their spread.
We report on an imported case of typhoid fever as previ-
ously described in other developed countries [16].
Patients with typhoid fever usually have a history of pro-
longed fever, headache and abdominal discomfort. There
are no distinctive clinical features, and definitive diagno-
sis requires isolation of S. typhi from blood, bone marrow,
stool, or urine cultures [5]. Our patient had fever with
upper airway symptoms and showed typical lesions
observed in oral candidiasis.
To date, oropharyngeal candidiasis is an opportunistic
infection that generally develops in patients who have
been using inhaled steroids over a long period of time,
and those with cancer and AIDS [17,18]. Because our
patient did not belong to any of the three categories of
patients reported above, we performed an HIV test to rule
out any recent HIV infection; the result was negative [19].
We noticed that the CD4+ cell count was low in the acute
phase of disease and improved gradually until normaliza-
tion within 3 weeks. These findings support the hypothe-
sis that S. typhi could lead to a progressive reduction of
CD4+ T helper cell population as already demonstrated
by a previous study performed on mice infected with S.
typhimurium [20].
In conclusion, to our knowledge our patient is the first
reported case of typhoid fever the onset of which was
accompanied by oropharyngeal candidiasis, suggesting a
close correlation between S. typhi infection and transitory
immunodepression.
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